US OptionsDetailed Quotes
LUNR241213P4500
- 0.00
- 0.000.00%
15min DelayClose Dec 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest4.50Strike Price0.00Turnover0.00%IV61.49%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma233.70Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intuitive Machines Stock Discussion
Sign in to post a comment
$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...
+4
1
6
$Intuitive Machines (LUNR.US)$
why insider is like selling crazyy?
why insider is like selling crazyy?
5
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
9
1
4
$Intuitive Machines (LUNR.US)$ what is the next milestone?
1
$Intuitive Machines (LUNR.US)$
Why is this stock volume so low 😆 i have a good insight for their future potential tho
Why is this stock volume so low 😆 i have a good insight for their future potential tho
1
11
$Intuitive Machines (LUNR.US)$
guaranteed to trade 300% higher come successful landing.
GUARANTEED.
FREE not financial advice
guaranteed to trade 300% higher come successful landing.
GUARANTEED.
FREE not financial advice
2
2
No comment yet
Millaai : Are you being trapped and looking for a rescuer everywhere?
Growth Investor27 : Good info, NEXLIZET is a great drug, my brother takes it. ESPR stock is undervalued, should be above $5
Growth Investor27 Millaai : The author has been buying below $2 so your comment is off. This research article has all the due diligence to see, other than the fact Institutions have been heavly buying this year, fintel shows now 74% owned. ESPR is a good investment.
104248191 : please f o
Detached House Millaai : You are wrong. Though short term looks like the price is consolidating, the weekly chart looks promising! So look at the chart to see if it aligns with the fundamentals before criticising others!
View more comments...